ORGANIC
LETTERS
2008
Vol. 10, No. 15
3295-3298
Total Synthesis of (-)-Saliniketals A
and B†
Ian Paterson,* Mina Razzak, and Edward A. Anderson
UniVersity Chemical Laboratory, Lensfield Road, Cambridge CB2 1EW, U.K.
Received May 20, 2008
ABSTRACT
A stereocontrolled total synthesis of the orthinine decarboxylase inhibitors saliniketals A and B is described. Key features of the 17-step route
include the use of two boron aldol/reduction sequences to control six of the nine stereocenters, an intramolecular Wacker-type cyclization to
install the bicyclic acetal core, and a late-stage Stille coupling to append the requisite (2Z,4E)-dienamide.
Saliniketals A (1) and B (2), isolated in 2007 by Fenical
and co-workers from the marine actinomycete Salinispora
arenicola, are inhibitors of ornithine decarboxylase (ODC)
induction.1 ODC hyperactivity is a marker of tumorigenesis
and is often seen in epithelial tumors of the colon, skin,
prostate, and stomach.2 As such, ODC inhibitors may
potentially be valuable chemotherapeutic or chemopreven-
tative agents.3
The novel structures of these unusual bioactive polyketides,
comprising a 2,8-dioxabicyclo[3.2.1]octane ring featuring an
elaborate side chain at C11 that terminates in an unsaturated
primary amide, were determined mainly by 2D-NMR
spectroscopic methods, with the absolute configuration
assigned by Mosher ester analysis. Intriguingly, the salini-
ketals show a structural resemblance to the ansa chain of
the rifamycin antibiotics, which co-occur within the fermen-
tation broth. By employing our versatile boron aldol meth-
odology, we now report the first total synthesis of saliniketals
A and B, invoking a late-stage diversification strategy to
append the requisite dienamide terminus.
As outlined in Scheme 1, we envisaged that both salini-
ketal A (1) and its more oxygenated congener, saliniketal B
(2), may be accessible from the common C4-C17 interme-
diate 3. This is primed for a Stille coupling4 with either vinyl
bromide 4 or 5 to install the appropriate (2E,4Z)-dienamide.
Disconnection of the C8-C9 bond in 3 reveals aldehyde 6
and ethyl ketone (S)-7, where the use of a substrate-controlled
anti-aldol /reduction sequence5 would enable installation of
the C6-C9 stereotetrad. The dioxabicyclic core present in
6 might then be constructed by an intramolecular Wacker-
type cyclization of the olefinic 1,3-diol 8. This diol would
itself be configured using a reagent-controlled syn-aldol
reaction, now requiring the use of the enantiomeric ethyl
ketone (R)-7.
Commencing with the reagent-controlled aldol reaction of
(R)-7 (Scheme 2),5 formation of the (Z)-boron enolate6 9 ((+)-
Ipc2BOTf, i-Pr2NEt), followed by addition of 4-pentenal,
† Dedicated to the late Jonathan (Joe) Spencer, a greatly missed colleague
and friend.
(1) Williams, P. G.; Asolkar, R. N.; Kondratyuk, T.; Pezzuto, J. M.;
Jensen, P. R.; Fenical, W. J. Nat. Prod. 2007, 70, 83.
(4) (a) Stille, J. K. Angew. Chem., Int. Ed. 1986, 25, 508. (b) Farina,
V.; Krishnamurthy, V.; Scott, W. J. Org. React. 1997, 50, 1.
(5) (a) Paterson, I.; Norcross, R. D.; Ward, R. A.; Romea, P.; Lister,
M. A. J. Am. Chem. Soc. 1994, 116, 11287. (b) Paterson, I.; Cumming,
J. G.; Ward, R. A.; Lamboley, S. Tetrahedron 1995, 51, 9393. (c) Paterson,
I.; Perkins, M. V. Tetrahedron 1996, 52, 1811.
(2) (a) Saunders, L. R.; Verdin, E. Mol. Cancer Ther. 2006, 5, 2777.
(b) Thomas, T.; Thomas, T. J. Cell. Mol. Life Sci. 2001, 58, 244.
(3) (a) Basuroy, U. K.; Gerner, E. W. J. Biochem. 2006, 139, 27. (b)
Gerner, E. W., Jr Nat. ReV. Cancer 2004, 4, 781.
10.1021/ol801148d CCC: $40.75
Published on Web 06/26/2008
2008 American Chemical Society